Tickling may be evolutionarily ancient and recognized across cultures, but science has only scratched the surface of this ...
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s ...
Reported positive Phase 2b RewinD-LB clinical data at CTAD 2025; additional analyses to be presented at AD/PD 2026 Obtained ...
Disruptive Futures Institute Affirms Metaruptions Concept as Word of the Year, Demonstrating Prescient Framework that Predicted the Collapse of Isolated Trends The world still chases trends as ...